MindMend Biotech LLC is an innovative biomedical engineering company focused on developing wearable biosensors for neurodegenerative diseases, starting with Parkinson’s. Our interdisciplinary approach combines advanced materials science, embedded electronics, and electrochemical sensing with AI-powered signal analysis to deliver clinically meaningful, real-time neurological monitoring. As a Woman-Owned Small Business, MindMend Biotech is committed to advancing equitable and continuous healthcare—especially in underserved rural communities—through decentralized clinical trial solutions and accessible diagnostic and monitoring tools. We mobilize the right minds, methods, and materials to improve clinical trial quality, accelerate early detection, and support inclusive healthcare innovation
MindMend Biotech develops cutting-edge wearable biosensor platforms for neurodegenerative disease monitoring, with a focus on:
Our team of genetic engineers works on developing gene therapies for a variety of genetic diseases. We use CRISPR/Cas9 technology and other cutting-edge techniques to c
· First-in-class wearable alpha-synuclein sensor using EIS and nanomaterials
· FDA regulatory planning aligned with Breakthrough Device and clinical use
· Integration of data science, electrochemistry, and human-centered design
· Focus on rural, remote, and underserved populationseate therapies that have the potential to cure genetic diseases.
We use biotechnology to create sustainable and environmentally-friendly industrial processes. Our team of experts works on developing new and innovative ways to produce chemicals, fuels, and other products.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.